Role of AST120 for Sarcopenia Prevention in Pre-dialysis Chronic Kidney Disease
Status:
Completed
Trial end date:
2020-07-14
Target enrollment:
Participant gender:
Summary
This study is to assess the effect of 48 weeks administration of Renamezin capsule on
prevention of sarcopenia in pre-dialysis patients with chronic kidney disease.